鼻用减充血剂的临床应用暨药物性鼻炎的诊治专家共识(2022，北京)

Expert consensus on clinical application of nasal decongestant and management of rhinitis medicamentosa (2022, Beijing)

摘要:

鼻用减充血剂可以快速缓解鼻塞，但长期过量使用可导致药物性鼻炎。目前临床上对鼻用减充血剂的使用和药物性鼻炎的治疗还存在很多误区。鉴于此，中国鼻病研究协作组召集国内中青年鼻科专家，基于临床经验和循证医学证据制订了鼻用减充血剂的临床应用暨药物性鼻炎的诊治专家共识。本共识系统总结了临床应用鼻用减充血剂治疗鼻塞的注意事项及药物性鼻炎的治疗原则，旨在指导并规范临床应用鼻用减充血剂，并正确有效地治疗药物性鼻炎。

Abstract:

Nasal decongestant is known to relieve nasal congestion rapidly and effectively. However, overdose and long-term use of nasal decongestant may cause rhinitis medicamentosa. Currently, there are still some controversial issues in the clinical use of nasal decongestant and management of rhinitis medicamentosa. For this reason, the Chinese Rhinopathy Research Cooperation Group convened domestic young and middle-aged rhinology experts to formulate an expert consensus on clinical use of nasal decongestant and management of rhinitis medicamentosa based on clinical experience and evidence-based medicine. This consensus systematically summarizes the relevant issues in order to guide and standardize clinicians to use nasal decongestant and treat rhinitis medicamentosa.